Literature DB >> 26688376

Lifetime cost of meningococcal disease in France: Scenarios of severe meningitis and septicemia with purpura fulminans.

Stève Bénard1, Claire Wright2, Jimmy Voisine3, Catherine W Olivier4, Joël Gaudelus5.   

Abstract

Invasive meningococcal disease (IMD) is life-threatening and can result in severe sequelae. In France, no data have been published on the costs of severe IMD cases. Two realistic scenarios were developed with national experts (clinicians and social workers): a 6-year-old child with purpura fulminans with amputation of both legs below the knee (case A) and a 3-year-old with meningitis and severe neurological sequelae (case B). Additional scenarios included other typical sequelae of IMD such as chronic kidney disease (CKD), profound deafness and epilepsy. Data on healthcare, disability, educational and other resource use were obtained from experts and families of patients with similar sequelae. Unit costs (2013) were mainly obtained from the literature and the National Health Insurance (NHI). Time horizon was based on life expectancies of patients (77 and 55 years, respectively). A 4% discount rate decreasing to 2% after 30 years was applied. Costs are presented from the perspective of the NHI, publicly funded organizations and patients' families or their private health insurances. purpura fulminans with amputations is associated with a lifelong discounted cost of €768,875. Adding CKD doubles the amount (€1,480,545). Meningitis with severe neuro-cognitive sequelae results in a lifelong discounted cost of €1,924,475. Adding profound deafness and epilepsy slightly increases the total cost (€2,267,251). The first year is the most expensive in both scenarios (€166,890 and €160,647 respectively). The main cost drivers for each scenario are prostheses and child/adult stays in healthcare facilities, respectively. Overall, patients' families or his private insurance had to pay around 13% of total cost (101,833€ and 258,817€, respectively). This study fills a gap in the body of knowledge on IMD sequelae care and lifetime costs in France. The potentially high economic burden of IMD, in addition to its physical, psychological and social burden, reinforces the need for prevention.
Copyright © 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cost; France; Invasive meningococcal disease; Management; Prevention

Mesh:

Year:  2015        PMID: 26688376     DOI: 10.1016/j.jiph.2015.10.016

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  6 in total

1.  Costs of Invasive Meningococcal Disease: A Global Systematic Review.

Authors:  Bing Wang; Renee Santoreneos; Hossein Afzali; Lynne Giles; Helen Marshall
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

2.  Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

Authors:  Femke van Kessel; Caroline van den Ende; Anouk M Oordt-Speets; Moe H Kyaw
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

3.  Development of a multiple cross displacement amplification combined with nanoparticles-based biosensor assay to detect Neisseria meningitidis.

Authors:  Shijun Li; Chunting Liu; Ying Liu; Qing Ma; Yue Wang; Yi Wang
Journal:  Infect Drug Resist       Date:  2019-07-15       Impact factor: 4.003

4.  Clinical and economic burden of invasive meningococcal disease: Evidence from a large German claims database.

Authors:  Liping Huang; Olivia Denise Heuer; Sabrina Janßen; Dennis Häckl; Niklas Schmedt
Journal:  PLoS One       Date:  2020-01-28       Impact factor: 3.240

5.  Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease-Real-World Data Analysis Using the French National Claims Database (SNIIRAM).

Authors:  Jing Shen; Stéphane Bouée; Emmanuel Aris; Corinne Emery; Ekkehard C Beck
Journal:  Infect Dis Ther       Date:  2021-11-17

6.  The epidemiology of meningococcal meningitis: multicenter, hospital-based surveillance of meningococcal meningitis in Iraq.

Authors:  Tarek Al-Sanouri; Sabah Mahdi; Ilham Abu Khader; Asaad Mahdi; Alp Dogu; Amine Amiche; Sereen Iweir; Mudhafar Qader; Adel Belbaisi; Riyad AlHilfi
Journal:  IJID Reg       Date:  2021-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.